Prices delayed by at least 15 minutes | Print
Gabelli Merchant Partners PLC (GMP)
ORD USD0.01Open
$7.00
Previous close
$7.00
Trade high
$7.00
Estimated NAV
10.56
Year high
$8.60
Year low
$7.00
Premium / Discount
-33.71%
Market capitalisation
$48.49 mn
Volume
2,371
Dividend yield
2.23%
Ongoing charge
1.83%
ISIN
GB00BD8P0741
This share can be held in a Dealing accountStocks and shares ISALifetime ISASIPP
Before investing please read:
Share price
Net asset value (NAV)
| Estimated NAV | 10.56 |
|---|---|
| Latest actual NAV | 10.56 |
| Latest actual NAV date | 05 November 2026 |
| 12m average premium/discount | -22.63% |
Top 10 holdings
| Holdings 30/09/2019 | % of assets |
|---|---|
| Celgene Corp | 6.32 |
| SunTrust Banks Inc | 4.81 |
| Medidata Solutions Inc | 4.51 |
| Zayo Group Holdings Inc | 4.47 |
| Versum Materials Inc | 4.38 |
| Mellanox Technologies Ltd | 4.22 |
| Allergan PLC | 3.77 |
| WABCO Holdings Inc | 3.65 |
| Spark Therapeutics Inc | 3.52 |
| Buckeye Partners LP | 3.43 |
Investment objective
To seek to generate total return, consisting of capital appreciation and current income for the long term. The Company will seek a secondary objective of the protection of capital, uncorrelated to equity and fixed income markets. To meet its investment objective by utilising the Gabelli Private Market Value (PMV) with a CatalystTM, investment methodology, maintaining a diversified portfolio of event merger arbitrage strategies to seek to create an optimal risk/ reward profile for the portfolio. The Company will invest globally although it is expected to have an emphasis on securities traded in the United States, predominantly equity securities issued by companies of any market capitalisation.
Morningstar ratingTM
News
Recent trades
| Date | Time | Price | Quantity | Value |
|---|---|---|---|---|
| 02/11/2026 | 04:35:02 | 7 | 2,371 | 16,597.00 |
| 28/10/2026 | 08:00:25 | 7 | 3,429 | 24,003.00 |
| 26/10/2026 | 04:35:18 | 7 | 1,200 | 8,400.00 |
| 02/09/2026 | 08:00:23 | 7.3 | 4,374 | 31,930.20 |